Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Corsica Health vs The Virtual NP

Corsica Health
Graded #193

Higher grade

vs+5.5
The Virtual NP
Graded #316

Lower grade

The verdict

Corsica Health takes it — 66.3/100 to 60.8/100.

Corsica Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCorsica Health +3
48
45
Dose & formulationCorsica Health +24
77
53
Clinical oversightThe Virtual NP +7
87
94
Labs & monitoringEven
54
54
FulfillmentCorsica Health +11
75
64
Contract termsEven
55
55
Corsica Health · left barThe Virtual NP · right bar

The numbers

MetricCorsica HealthThe Virtual NP
WeighScore66.3/10060.8/100
GradeCC
Scorecard rank#193#316
Semaglutide$249/mo (compounded)Not disclosed
Tirzepatide$349/mo (compounded)Not disclosed
CoverageCoverage not published7 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Corsica Health

Graded #193 · C

Strengths

  • Public pricing shown for both compounded and brand-name options — a real transparency advantage
  • $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
  • LegitScript Certified
  • Clear 3-step intake: Assessment, Provider Review, Receive Medication
  • $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced

Where it loses points

  • Legal entity name and state of incorporation not disclosed on the site
  • Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
  • Per-state availability not listed publicly
  • First-month promotional pricing not disclosed
  • Lab-work inclusion not clearly disclosed
The Virtual NP

Graded #316 · C

Strengths

  • FDA-approved branded Zepbound and Wegovy only, no compounded
  • Transparent fees: 99 visit or 75 per month membership
  • HSA/FSA accepted and prior authorization assistance offered
  • NP-led with same or next-day booking and home shipping

Where it loses points

  • Branded only, so medication cost is high and billed separately
  • Limited to seven states
  • No compounded lower-cost GLP-1 alternative
  • Single-provider practice may limit scale and hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard